Also the elderly and poor who cannot afford the prescriptions.

GLP-1 drugs range from $100-$200 a month from mail order compounding pharmacies, or $500 a month on "discount" plans from the drug makers.

This change to FDA enforcement is going to prevent a lot of people from getting help.

The positive impact of GLP-1 drugs is huge, but the price is out of reach for most people. The people who most benefit, elderly obese people at high risk of injury due to falls, who have a low quality of life from morbid obesity, are least able to afford access to the drugs.

These compounding pharmacies were improving a lot of lives.